Shuttle Pharmaceuticals Holdings, Inc.·4

Jul 9, 5:50 PM ET

HRT FINANCIAL LP 4

4 · Shuttle Pharmaceuticals Holdings, Inc. · Filed Jul 9, 2026

Research Summary

AI-generated summary of this filing

Updated

Shuttle Pharmaceuticals (SHPH) 10% Owner Sells Shares

What Happened
HRT FINANCIAL LP, a reported 10% owner of Shuttle Pharmaceuticals Holdings, Inc. (SHPH), sold a total of 29,111 shares in two open-market transactions: 10,580 shares at $3.33 on 2026-07-07 (reported value $35,231) and 18,531 shares at $3.52 on 2026-07-08 (reported value $65,229). These were sales (S) rather than purchases; sales by large holders can be routine portfolio rebalancing and do not necessarily signal company-specific concerns.

Key Details

  • Transaction dates and prices:
    • 2026-07-07: 10,580 shares sold @ $3.33 — $35,231 reported
    • 2026-07-08: 18,531 shares sold @ $3.52 — $65,229 reported
  • Total shares sold: 29,111; total reported proceeds: ~$100,460
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Transaction type: Reported as "Open market or private sale" (S = Sale).
  • Filing date: Form 4 filed 2026-07-09. No late-filing flag was provided in the data supplied.

Context
HRT FINANCIAL LP is a 10% owner (an institutional/large shareholder), not an individual executive—such sales often reflect portfolio management rather than insider views on near-term company performance. The filing shows straight sales, not option exercises, gifts, or awards, and there are no footnotes provided here (e.g., 10b5-1 plan or tax withholding) in the supplied data.

Insider Transaction Report

Form 4Exit
Period: 2026-06-29
Transactions
  • Sale

    Common Stock

    2026-07-07$3.33/sh10,580$35,23170,805 total
  • Sale

    Common Stock

    2026-07-08$3.52/sh18,531$65,22952,274 total
Signature
Adam Nunes|2026-07-09

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT